Spots Global Cancer Trial Database for adrenocortical carcinoma
Every month we try and update this database with for adrenocortical carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma | NCT04187404 | Adrenocortical ... Pheochromocytom... Paraganglioma | EO2401 Nivolumab | 18 Years - | Enterome | |
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
| Surgery and Heated Chemotherapy for Adrenocortical Carcinoma | NCT01833832 | Adrenocortical ... Peritoneal Carc... | Cisplatin Cytoreductive s... sodium thiosulf... | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma | NCT00924989 | Adrenocortical ... | OSI-906 Placebo | 18 Years - | Astellas Pharma Inc | |
| The Impact of Mitotane Therapy on Serum Free Proteins in Patients With Adrenocortical Carcinoma | NCT05344027 | Adrenocortical ... | Mitotane | 19 Years - 85 Years | King's College Hospital NHS Trust | |
| A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma | NCT04187404 | Adrenocortical ... Pheochromocytom... Paraganglioma | EO2401 Nivolumab | 18 Years - | Enterome | |
| Milademetan in Advanced/Metastatic Solid Tumors | NCT05012397 | Solid Tumors Head and Neck C... Cholangiocarcin... Sarcoma Lung Adenocarci... Bladder Urothel... Stomach Adenoca... Breast Cancer I... Ovarian Carcino... Cervical Cancer Non Small Cell ... Gastric Cancer Biliary Tract C... Melanoma Pancreas Cancer MDM2 Gene Ampli... Testicular Germ... Adrenocortical ... | RAIN-32 | 18 Years - | Rain Oncology Inc | |
| Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma | NCT00457587 | Adrenocortical ... Cushing's Syndr... | 18 Years - | University of Wuerzburg | ||
| Gene Modified Immune Cells (IL13Ralpha2 CAR T Cells) After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors | NCT04119024 | Metastatic Mali... Metastatic Mela... Pathologic Stag... Pathologic Stag... Recurrent Malig... Refractory Mali... Uveal Melanoma Acral Melanoma Neuroendocrine ... Paraganglioma Pheochromocytom... Adrenocortical ... Pancreatic Neur... Thyroid Cancer Breast Cancer Lung Adenocarci... Head and Neck S... | Biopsy Biospecimen Col... Computed Tomogr... Cyclophosphamid... Fludarabine Pho... Fludeoxyglucose... IL13Ralpha2-spe... Magnetic Resona... Positron Emissi... | 18 Years - 70 Years | Jonsson Comprehensive Cancer Center | |
| Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors | NCT00002608 | Adrenocortical ... Brain and Centr... Head and Neck C... Liver Cancer Malignant Mesot... Pheochromocytom... Sarcoma | cisplatin doxorubicin hyd... tamoxifen citra... conventional su... radiation thera... | - 65 Years | National Cancer Institute (NCI) | |
| Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card | NCT02672020 | Adrenal Gland N... | omics identity ... | 15 Years - | Assistance Publique - Hôpitaux de Paris | |
| Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma | NCT04318730 | Adrenocortical ... | Camrelizumab | 18 Years - | West China Hospital | |
| Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC) | NCT05913427 | Adrenocortical ... | Etoposide, doxo... Etoposide, doxo... | 18 Years - | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma | NCT05660889 | Adrenocortical ... | Blood sampling. | 18 Years - | Erasmus Medical Center | |
| Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted Adrenalectomy | NCT06050057 | Adrenal Tumor Adrenal Disease Adrenal Mass Adrenalectomy; ... Adrenal Hyperpl... Adrenal Gland M... Adrenal Cortex ... Pheochromocytom... Cushing Syndrom... Conn Adenoma Adrenocortical ... Adrenocortical ... Adrenocortical ... | 18 Years - | University Hospital Olomouc | ||
| Efficacy of Adjuvant Mitotane Treatment (ADIUVO) | NCT00777244 | Adrenocortical ... | MITOTANE | 18 Years - | University of Turin, Italy | |
| Efficacy of Adjuvant Mitotane Treatment (ADIUVO) | NCT00777244 | Adrenocortical ... | MITOTANE | 18 Years - | University of Turin, Italy | |
| A Phase 1/2 Study of [225Ac]-FPI-1434 Injection | NCT03746431 | Advanced Solid ... Endometrial Can... Cervical Cancer Ovarian Cancer Breast Cancer Triple Negative... HER2-negative B... Head and Neck S... Adrenocortical ... Uveal Melanoma | [111In]-FPI-154... [225Ac]-FPI-143... FPI-1175 Infusi... [225Ac]-FPI-143... | 18 Years - | Fusion Pharmaceuticals Inc. | |
| Studying Genes in Samples From Younger Patients With Adrenocortical Tumor | NCT01528956 | Adrenocortical ... | DNA methylation... RNA analysis gene expression... nucleic acid se... polymorphism an... | - 21 Years | Children's Oncology Group | |
| A Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab in Combination With Mitotane in Patients With Advanced Adrenocortical Carcinoma | NCT05634577 | Adrenocortical ... | Mitotane Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Possible New Therapy for Advanced Cancer | NCT01832974 | Adrenocortical ... | IL-13-PE | 18 Years - | INSYS Therapeutics Inc | |
| Adrenal Vein Sampling as a Tool to Identify Biomarkers That Aid the Diagnosis of Adrenocortical Carcinoma | NCT05660889 | Adrenocortical ... | Blood sampling. | 18 Years - | Erasmus Medical Center | |
| Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging | NCT00445718 | Adrenocortical ... Localized Resec... Precancerous Co... | computed tomogr... 3-Tesla magneti... Abdominal Sonog... | - 6 Months | Children's Oncology Group | |
| Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma | NCT01514526 | Adrenocortical ... | Dovitinib | 18 Years - | Spanish Oncology Genito-Urinary Group | |
| Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines | NCT03257891 | Adrenocortical ... | Cabazitaxel | 18 Years - | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| Structured Evaluation of adRENal Tumors Discovered Incidentally - Prospectively Investigating the Testing Yield | NCT02324647 | Adrenal Inciden... Adrenocortical ... | 18 Years - | University Medical Center Groningen | ||
| Evaluation of Side Effects of Mitotane | NCT00568139 | Adrenocortical ... | - | University of Wuerzburg | ||
| Adrenal Tumors - Pathogenesis and Therapy | NCT00669266 | Adrenal Tumors Adrenocortical ... Cushing Syndrom... Conn Syndrome Pheochromocytom... | - 100 Years | University of Wuerzburg | ||
| S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery | NCT00002921 | Adrenocortical ... | suramin therapeutic hyd... | 18 Years - | SWOG Cancer Research Network | |
| First-in-human Evaluation of [18F]CETO | NCT05361083 | Primary Aldoste... Primary Aldoste... Adrenal Cushing... Non-Secretory A... Adrenocortical ... | F18CETO | 18 Years - | Uppsala University | |
| European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma | NCT05763524 | Adrenocortical ... | Adrenalectomy w... | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Phase 1 Study of 68Ga-R8760 | NCT05999292 | Adrenocortical ... | 68Ga-R8760 inje... 68Ga-R8760 inje... | 18 Years - | Radionetics Oncology | |
| Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) | NCT04373265 | Adrenocortical ... | Relacorilant Pembrolizumab | 18 Years - | Corcept Therapeutics | |
| Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma | NCT00324012 | Adrenocortical ... | cisplatin, taxo... | 18 Years - | Rigshospitalet, Denmark | |
| A Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma | NCT00924989 | Adrenocortical ... | OSI-906 Placebo | 18 Years - | Astellas Pharma Inc | |
| Activity of Abiraterone Acetate in the Management of Cushing's Syndrome in Patients With Adrenocortical Carcinoma | NCT03145285 | Cushing Syndrom... Adrenocortical ... | Abiraterone Ace... | 18 Years - | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| Cabozantinib in Advanced Adrenocortical Carcinoma | NCT03612232 | Adrenocortical ... | Cabozantinib-s-... | 18 Years - | Wuerzburg University Hospital | |
| Adjuvant Chemotherapy vs. Observation/Mitotane After Primary Surgical Resection of Localized Adrenocortical CarcInoma | NCT03723941 | Adrenocortical ... | Cisplatin plus ... Observation or ... | 18 Years - | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | |
| A Prospective Cohort Study for Patients With Adrenal Diseases | NCT03474237 | Adrenal Adenoma Cushing Syndrom... Pheochromocytom... Adrenal Inciden... Adrenocortical ... Primary Hyperal... | Hormone study a... | 19 Years - | Seoul National University Hospital | |
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | NCT01048892 | Adrenocortical ... Gastrointestina... Kidney Cancer Neuroblastoma Retinoblastoma Sarcoma | Seneca Valley v... cyclophosphamid... laboratory biom... pharmacological... | 3 Years - 21 Years | Children's Oncology Group | |
| Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma | NCT02015026 | Adrenocortical ... | 12 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Natural History and Tissue Acquisition Study of Adrenocortical Carcinoma | NCT02015026 | Adrenocortical ... | 12 Years - 100 Years | National Institutes of Health Clinical Center (CC) | ||
| Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | NCT00436657 | Peritoneal Neop... Retroperitoneal... Gastrointestina... Adenocarcinoma Neuroblastoma Ovarian Neoplas... Sarcoma Adrenocortical ... Wilms Tumor Rhabdomyosarcom... Desmoplastic Sm... | CHPP of Cisplat... Abdominal Surge... | 3 Years - 18 Years | M.D. Anderson Cancer Center | |
| Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC) | NCT04358107 | Adrenocortical ... | - | National Institutes of Health Clinical Center (CC) | ||
| Towards an Easy-to-use Adrenal Cancer/Tumor Identity Card | NCT02672020 | Adrenal Gland N... | omics identity ... | 15 Years - | Assistance Publique - Hôpitaux de Paris | |
| Phase 1 Study of ATR-101 in Subjects With Advanced Adrenocortical Carcinoma | NCT01898715 | Adrenocortical ... Adrenal Cancer ACC | ATR-101 | 18 Years - | Millendo Therapeutics, Inc. | |
| A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) | NCT03833700 | Solid Neoplasms Colorectal Neop... Gastrointestina... | E7386 | 18 Years - | Eisai Inc. | |
| Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma | NCT02673333 | Adrenocortical ... | Pembrolizumab | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma | NCT02673333 | Adrenocortical ... | Pembrolizumab | 18 Years - | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
